However, the very recent data by Rolny et al (2008) suggest a reconsideration of this semaphorin as a multifaceted regulator of cancer progression: SEMA3B inhibited tumour growth in mice but simultaneously and unexpectedly triggered metastasis by activating the signalling kinase p38. Here, SEMA3B is linked to cancer.